✦ LIBER ✦

Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice

✍ Scribed by Robert J. Melder; Blaire L. Osborn; Todd Riccobene; Palanisamy Kanakaraj; Ping Wei; Guoxian Chen; David Stolow; Wendy Green Halpern; Thi-Sau Migone; Qi Wang; Krzysztof J. Grzegorzewski; Gilles Gallant

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 649 KB
Volume: 54
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-004-0624-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and stability of the ch

Pharmacokinetics and stability of the ch14.18–interleukin-2 fusion protein in mice

✍ Kari Kendra; Jacek Gan; Melody Ricci; Jean Surfus; Anisa Shaker; Michael Super; 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 216 KB

Catalytic activity of an in vivo tumor t

Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein

✍ Jeetendra Bhatia; Surinder K. Sharma; Kerry A. Chester; R. Barbara Pedley; Rober 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 154 KB

## Antibody -directed enzyme prodrug therapy (ADEPT) targets an enzyme selectively to a tumor where it converts a relatively non-toxic prodrug to a potent cytotoxic drug. Previous clinical work using antibody-enzyme chemical conjugates has been limited by the moderate efficiency of tumor targeting

Sensitization by interleukin-lα of carbo

Sensitization by interleukin-lα of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cells in vitro and in vivo

✍ Zheng Wang; Kang Bo Lee; Eddie Reed; Biranda K. Sinha 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 513 KB

Cytokines are directly cytotoxic to tumor cells in vitro and in vivo, and interleukinla (ILla) potentiates the cytotoxicity of a number of clinically active drugs in several human tumor cells, including carcinomas of the breast and ovary. In this study, we found that ILla potentiated the cytotoxicit

Deficient tumor-specific immunity in old

Deficient tumor-specific immunity in old mice: in vivo mediation by suppressor cells, and correction of the defect by interleukin 2 supplementation in vitro but not in vivo

✍ Martine Bruley-Rosset; Béatrice Payelle 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Potent anti-tumor effects of an anti-CD2

Potent anti-tumor effects of an anti-CD24 ricin A-chain immunotoxin in vitro and in a disseminated human Burkitt's lymphoma model in SCID mice

✍ Roland Schnell; Ali A. Katouzi; Christoph Linnartz; Gisela Schoen; Silke Drillic 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 859 KB

A new anti-CD24 immunotoxin (IT), SWAl l.dgA, was constructed by coupling the MAb SWAl I via the bivalent linker SMPT to deglycosylated r i c h A-chain (dgA). The effects of SWAl I .dgA were evaluated in vitro against the B-precursor leukemia cell line REH, the non-6-non-T acute lymphoblastic leukem

In vitro and in vivo properties of a dim

In vitro and in vivo properties of a dimeric bispecific single-chain antibody IgG-fusion protein for depletion of CCR2+ target cells in mice

✍ Martin A. Schneider; Hilke Brühl; Alexandra Wechselberger; Josef Cihak; Manfred 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB